Exact Mass: 385.1285222
Exact Mass Matches: 385.1285222
Found 427 metabolites which its exact mass value is equals to given mass value 385.1285222,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
S-Inosyl-L-homocysteine
L-homocysteine substituted at sulfur by a 5-deoxyinosin-5-yl group.
Polycarpine
Nocardicin G
A monobactam obtained by formal condensation of the carboxy group of (2R)-amino(4-hydroxyphenyl)acetic acid with the amino group of (2R)-[(3S)-3-amino-2-oxoazetidin-1-yl](4-hydroxyphenyl)acetic acid
Tepoxalin
C20H20ClN3O3 (385.11931200000004)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Tepoxalin is a dual inhibitor of COX and 5-lipoxygenase (5-LO) with potent anti-inflammatory activity and a favorable gastrointestinal profile[1].
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronide
This compound belongs to the family of O-Glucuronides. These are O-Glucuronides. Glucuronides in which the aglycone is linked to the carbohydrate unit through a o-glycosidic bond.
chromopyrrolic acid
C22H15N3O4 (385.10625100000004)
A pyrroledicarboxylic acid that is pyrrole-2,5-dicarboxylic acid in which the hydrogens at positions 3 and 4 have been replaced by indol-3-yl groups.
Prifinium Bromide
C22H28N. Br (385.14049880000005)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent Same as: D01377
Sarafloxacin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic Sarafloxacin is used for control of Campylobacter infections in poultr It is used for control of Campylobacter infections in poultry
N-Methylporphyroxine
N-Methylporphyroxine is an alkaloid from Papaver somniferum (opium poppy
Papaverrubine B
Papaverrubine B is found in opium poppy. Papaverrubine B is an alkaloid from Papaver rhoeas (corn poppy
Niazicin
C17H23NO7S (385.11951680000004)
Niazicin is a glucosinolate and a naturally occurring thiocarbamate. It has been isolated from the leaves of Moringa oleifera (horseradish tree). It is found in fats and oils, herbs and spices, and green vegetables. The trans and cis rotamers of niazicin (niazicin A and niazicin B, respectively) differ in the orientation of the NH group with respect to sulfur. Constituent of Moringa oleifera (horseradish tree). Niazicin A is found in fats and oils, herbs and spices, and green vegetables.
Glaucamine
Glaucamine is an alkaloid from Papaver rhoeas (corn poppy
Zeanoside C
Isolated from immature sweet corn kernels Zea mays (Gramineae). Zeanoside C is found in cereals and cereal products, fats and oils, and corn. Zeanoside A is found in cereals and cereal products. Zeanoside A is isolated from sweet corn kernels Zea mays (Gramineae).
Romucosine H
Romucosine H is found in cherimoya. Romucosine H is an alkaloid from Annona cherimola (cherimoya).
(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside
(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside is found in cereals and cereal products. (S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside is a constituent of rice bran Constituent of rice bran. (R)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside is found in cereals and cereal products.
Phosphatidylserine
Phosphatidylserine (PS) is a phospholipid nutrient found in fish, green leafy vegetables, soybeans and rice, and is essential for the normal functioning of neuronal cell membranes and activates Protein kinase C (PKC) which has been shown to be involved in memory function. In apoptosis, phosphatidylserine is transferred to the outer leaflet of the plasma membrane. This is part of the process by which the cell is targeted for phagocytosis. PS has been shown to slow cognitive decline in animal models. PS has been investigated in a small number of double-blind placebo trials and has been shown to increase memory performance in the elderly. Because of the potentail cognitive benefits of phosphatidylserine, the substance is sold as a dietary supplement to people who believe they can benefit from an increased intake. The dietary supplement was originally processed from bovine sources however Prion disease scares in the 1990s outlawed this process, and a soy-based alternative was adopted.
Nilvadipine
Nilvadipine is only found in individuals that have used or taken this drug. It is a calcium channel blocker (CCB) for treatment of hypertension.Nilvadipine inhibits the influx of extracellular calcium through myocardial and vascular membrane pores by physically plugging the channel. The decrease in intracellular calcium inhibits the contractile processes of smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload. C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
(R)-N-(1-Methyl-2-phenylethyl)adenosine
C19H23N5O4 (385.17499580000003)
D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents
2,5-Dioxopyrrolidin-1-YL 4-(pyren-1-YL)butanoate
3-Desmethylcolchicine
Alizarin complexone
(4As,5aS,6S,12aS)-1,6,10,11-tetrahydroxy-6-methyl-3,12-dioxo-4a,5,5a,12a-tetrahydro-4H-tetracene-2-carboxamide
C20H19NO7 (385.11614640000005)
(4As,5aR,6R,12aR)-1,10,11,12a-tetrahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
C20H19NO7 (385.11614640000005)
Colchiceine
Ecadotril
C21H23NO4S (385.13477180000007)
Fleroxacin N-oxide
C17H18F3N3O4 (385.12493440000003)
Isopropylphenyladenosine
C19H23N5O4 (385.17499580000003)
Minoxidil Glucuronide
n6-phenylisopropyladenosine
C19H23N5O4 (385.17499580000003)
3-Demethylcolchicine
3-Demethylcolchicine, a colchicine metabolite, possesses a hydroxy-group on its carbon ring that could participate in radical scavenging and markedly inhibits the carrageenin edema[1][2]. 3-Demethylcolchicine, a colchicine metabolite, possesses a hydroxy-group on its carbon ring that could participate in radical scavenging and markedly inhibits the carrageenin edema[1][2].
N-Methylporphyroxine
Amisulpride N-Oxide
CONFIDENCE standard compound; EAWAG_UCHEM_ID 3399 CONFIDENCE standard compound; INTERNAL_ID 2143
MAM-2201 N-pentanoic acid metabolite
C25H23NO3 (385.16778480000005)
3-[4-Methoxy-2-(trifluoromethyl)-6-quinolyl]prop-2-ynyl benzoate
Racecadotril
C21H23NO4S (385.13477180000007)
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
N2-(N2-L-Pyroglutamyl-L-glutaminyl)-L-glutamin|N2-(N2-L-pyroglutamyl-L-glutaminyl)-L-glutamine
(7bR)-7t-Acetylamino-2-hydroxy-1,3,9-trimethoxy-(7br,10ac)-6,7,7b,10a-tetrahydro-5H-benzo[a]cyclopenta[3,4]-cyclobuta[1,2-c]cyclohepten-8-on|(7bR)-7t-acetylamino-2-hydroxy-1,3,9-trimethoxy-(7br,10ac)-6,7,7b,10a-tetrahydro-5H-benzo[a]cyclopenta[3,4]-cyclobuta[1,2-c]cyclohepten-8-one|O2-De-Me-beta-Lumicolchicine
5-[(R)-Hydroxy-((S)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isochinolin-5-yl)-methyl]-benzo[1,3]dioxol-4-carbonsaeure|5-[(R)-hydroxy-((S)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-methyl]-benzo[1,3]dioxole-4-carboxylic acid
C20H19NO7 (385.11614640000005)
methyl 7-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-L-glycero-alpha-D-manno-heptopyranoside
C14H27NO11 (385.15840319999995)
(+-)-aryapavine|11-hydroxy-12-hydroxymethyl-1,10-dimethoxy-2,3-methylenedioxyberbine|12-hydroxymethyl-10,14-dimethoxy-5,8,13,13a-tetrahydro-6H-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-11-ol|12-Hydroxymethylprotoberberin|Aryapavin|Aryapavine
O-Butyl (E)-[4-(alpha-L-rhamnosyloxy)benzyl]thiocarbamate|O-butyl 4-[(alpha-L-rhamnosyloxy)benzyl]thiocarbamate
2-Desmethyl-beta-lumicolchicin|O2-Demethyl-beta-lumicolchicin|O3-De-Me-beta-Lumicolchicine
2-acetamido-2-deoxy-3-O-(beta-D-galactopyranosyl)-D-galactitol|2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-D-galactitol|beta-D-Gal-(1->3)-D-GalNAcol|beta-D-Galp(1->3)-D-GalNAc-ol|beta-Gal-(1-3)-GalNAc-ol
C14H27NO11 (385.15840319999995)
(-)-8-oxo-11-hydroxy-2,3,9,10-tetramethoxyberberine
(S)-4,9,10,11-tetramethoxy-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4,5:4,5]benzo[1,2,3-de]quinoline|Nor-Leucoxylonin|Norleucoxylonine
(+)-ocoxylonine|(S)-4,10,11-trimethoxy-7-methyl-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4,5:4,5]benzo[1,2,3-de]quinolin-9-ol|Ocoxylonin|Ocoxylonine
13-Methylberberine
C21H20ClNO4 (385.1080790000001)
13-Methylberberine chloride (13-Methylberberinium chloride), a berberine analogue, has anti-adipogenic and antitumor activities. 13-Methylberberine chloride (13-Methylberberinium chloride) increases production of IL-12 and inhibits the expression of iNOS at posttranscriptional level in macrophages activated with LPS[1][2][3]. 13-Methylberberine chloride (13-Methylberberinium chloride), a berberine analogue, has anti-adipogenic and antitumor activities. 13-Methylberberine chloride (13-Methylberberinium chloride) increases production of IL-12 and inhibits the expression of iNOS at posttranscriptional level in macrophages activated with LPS[1][2][3].
anisodamine
C17H24BrNO4 (385.08886040000004)
Anisodamine hydrobromide (6-Hydroxyhyoscyamine hydrobromide), a belladonna alkaloid, is a non-subtype-selective muscarinic and a nicotinic cholinoceptor antagonist. Anisodamine hydrobromide shows antioxidant, anti-inflammatory properties[1][2]. Anisodamine hydrobromide (6-Hydroxyhyoscyamine hydrobromide), a belladonna alkaloid, is a non-subtype-selective muscarinic and a nicotinic cholinoceptor antagonist. Anisodamine hydrobromide shows antioxidant, anti-inflammatory properties[1][2].
NCI60_001400
3-Desmethylcolchicine is a natural product found in Colchicum arenarium, Colchicum bivonae, and other organisms with data available. 3-Demethylcolchicine, a colchicine metabolite, possesses a hydroxy-group on its carbon ring that could participate in radical scavenging and markedly inhibits the carrageenin edema[1][2]. 3-Demethylcolchicine, a colchicine metabolite, possesses a hydroxy-group on its carbon ring that could participate in radical scavenging and markedly inhibits the carrageenin edema[1][2].
Sarafloxacin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3620 EAWAG_UCHEM_ID 3620; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 1035
Azasetron HCl
C17H21Cl2N3O3 (385.09598960000005)
Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV)[1].
3-Piperidinemethanol, 4-(4-fluorophenyl)-, (3S,4R)-glucuronide
Desmethylcolchicine
3-Demethylcolchicine, a colchicine metabolite, possesses a hydroxy-group on its carbon ring that could participate in radical scavenging and markedly inhibits the carrageenin edema[1][2]. 3-Demethylcolchicine, a colchicine metabolite, possesses a hydroxy-group on its carbon ring that could participate in radical scavenging and markedly inhibits the carrageenin edema[1][2].
(2S)-2-amino-3-[[(2R)-2-butanoyloxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
Lys-Met-OH
C16H23N3O6S (385.13074980000005)
Met-Lys-OH
C16H23N3O6S (385.13074980000005)
Nilvadipine
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Glaucamine
Papaverrubine B
(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside
Romucosine H
Zeanoside C
BIOTIN 4-AMIDOBENZOIC ACID SODIUM SALT
C17H20N3NaO4S (385.1072160000001)
N-[9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]-2-phenoxyacetamide
(R)?-?PIA
C19H23N5O4 (385.17499580000003)
D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents
Thiazolidine, 2-(4-methoxyphenyl)-3-(1-naphthalenylsulfonyl)- (9CI)
C20H19NO3S2 (385.0806304000001)
2,6-dimethyl-4-(3-nitrophenyl)-5-methoxycarbonyl-1,4-dihydropyridine-3-carboxylic acid 2-cyanoethyl ester
Ecadotril
C21H23NO4S (385.13477180000007)
D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
2,3-dimethylnaphtho[1,2-d]thiazolium tosylate
C20H19NO3S2 (385.0806304000001)
tert-butyl 4-(4-bromo-2-methoxyphenoxy)piperidine-1-carboxylate
C17H24BrNO4 (385.08886040000004)
BRL 37344, sodium salt
C19H21ClNNaO4 (385.1056736000001)
BRL 37344 sodium (BRL 37344A) is a specific β3-adrenergic receptor agonist. BRL 37344 sodium treatment significantly lowers the body weight of obese mice[1].
(+)-(5aR,10bS)-5a,10b-Dihydro-2-(2,4,6-trimethylphenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Chloride Monohydrate
(2S,4R)-1-(tert-butoxycarbonyl)-4-(tosyloxy)pyrrolidine-2-carboxylic acid
C17H23NO7S (385.11951680000004)
2-(6,7-DIMETHOXY-3,3-DIMETHYL-3,4-DIHYDRO-ISOQUINOLIN-1-YLMETHYLSULFANYL)-BENZOIC ACID
C21H23NO4S (385.13477180000007)
4-(4-(BENZO[D][1,3]DIOXOL-5-YL)-5-(PYRIDIN-2-YL)-1H-IMIDAZOL-2-YL)BENZOIC ACID
C22H15N3O4 (385.10625100000004)
3(4-DIMETHYLAMINO-1-NAPHTHYLAZO)-4-METHOXYBENZENESULFONIC ACID
C19H19N3O4S (385.10962140000004)
[7-(2-nitrooxyethoxy)-4-oxo-2-phenylchromen-5-yl] acetate
1H-1,2,4-triazole-5-carboxylic acid
C15H19N3O9 (385.11212439999997)
tert-butyl N-[4-(bromomethyl)phenyl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate
C17H24BrNO4 (385.08886040000004)
L-ASPARTIC ACID BIS-ALLYL ESTER P-TOLUENESULFONATE SALT
C17H23NO7S (385.11951680000004)
(R,S)-FMOC-1,3-DIHYDRO-2H-ISOINDOLE CARBOXYLIC ACID
Denibulin
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
2-[ethyl[3-methyl-4-[(5-nitro-2,1-benzisothiazol-3-yl)azo]phenyl]amino]ethanol
5-NAPHTHALEN-2-YL-7-TRIFLUOROMETHYL-PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLIC ACID ETHYL ESTER
2-METHOXY-5-(6-METHOXY-7-(2-METHOXYETHOXY)QUINAZOLIN-4-YLAMINO)CYCLOHEXA-2,5-DIENE-1,4-DIONE
(E)-4-Methyl-N-(2-oxo-1-phenyl-2-(piperidin-1-yl)ethylidene)benzenesulfonohydrazide
(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol
N-[(1R,2R)-2-aminocyclohexyl]-N-[3,5-bis(trifluoromethyl)phenyl]-Thiourea
C15H17F6N3S (385.10473140000005)
Azasetron
C17H20ClN3O3·HCl (385.09598960000005)
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV)[1].
Acumapimod
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2149 - Mitogen-Activated Protein Kinase Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
ethyl 2-piperazine-4-(4-trifluoromethyl)phenyl thiazole-5-carboxylate
ethyl 8-cyano-2-((4-fluorophenylthio)Methyl)-7-MethoxyiMidazo[1,2-a]pyridine-3-carboxylate
(-)-O,O-DIBENZOYL-L-TARTARIC ACID MONO(DIMETHYLAMIDE)
C20H19NO7 (385.11614640000005)
1-(2,4-dimethylbenzyl)-6-(1-methyl-1H-pyrrol-2-yl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridine-3-carbonitrile
Ciprofloxacin Hydrochloride
C17H21ClFN3O4 (385.12045480000006)
D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic Ciprofloxacin (Bay-09867) hydrochloride monohydrate is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin hydrochloride monohydrate induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin hydrochloride monohydrate has anti-proliferative activity and induces apoptosis. Ciprofloxacin hydrochloride monohydrate is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity[1][2][3][4].
2,2,2-TRIFLUORO-1-(4-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-YL)PIPERAZIN-1-YL)ETHANONE
3-{isopropyl[(Trans-4-Methylcyclohexyl)carbonyl]amino}-5-Phenylthiophene-2-Carboxylic Acid
C22H27NO3S (385.17115520000004)
6,8-Difluoro-1-(2-fluoroethyl)-7-(4-methyl-4-oxidopiperazin-4-ium-1-yl)-4-oxoquinoline-3-carboxylic acid
C17H18F3N3O4 (385.12493440000003)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones
12,13-Dihydro-3,9-dimethoxy-5H-Indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione
C22H15N3O4 (385.10625100000004)
2-Acetamido-2-deoxyglucosylgalactitol
C14H27NO11 (385.15840319999995)
2-[[oxo-(1-oxo-3,4-dihydro-1H-2-benzopyran-3-yl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester
C20H19NO5S (385.0983884000001)
2-phenyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-4-quinolinecarboxamide
C23H19N3OS (385.12487640000006)
2-[(4-fluorophenyl)sulfonyl-(2-pyridinyl)amino]-N-phenylacetamide
N-[2-[1-(4-fluoro-2-methylphenyl)sulfonyl-2-piperidinyl]ethyl]-N-methyloxamide
C17H24FN3O4S (385.14714760000004)
N2-[(1S,2R)-2-aminocyclohexyl]-N6-(3-chlorophenyl)-9-ethylpurine-2,6-diamine
2-chloro-4-fluoro-N-[4-methoxy-3-(4-methoxyphenyl)phenyl]benzamide
C21H17ClFNO3 (385.08809340000005)
7-Acetamido-10-hydroxy-1,2,3-trimethoxy-6,7-dihydrobenzo[a]heptalen-9(5H)-one
4-((3R,4S,5R)-4-Amino-3,5-dihydroxy-hex-1-ynyl)-5-fluoro-3-[1-(3-methoxy-1H-pyrrol-2-YL)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one
C20H20FN3O4 (385.14377720000005)
3(S)-Methylcarbamoyl-7-sulfoamino-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester
C16H23N3O6S (385.13074980000005)
3(R)-Methylcarbamoyl-7-sulfoamino-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester
C16H23N3O6S (385.13074980000005)
(4as)-5-[(2,4-Diaminopteridin-6-Yl)methyl]-4a,5-Dihydro-2h-Dibenzo[b,F]azepin-8-Ol
C21H19N7O (385.16510040000003)
[N-(3-Dibenzylcarbamoyl-oxiranecarbonyl)-hydrazino]-acetic acid
C20H23N3O5 (385.16376280000003)
Prifinium Bromide
C22H28BrN (385.14049880000005)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent
Omeprazole sodium hydrate
C17H20N3NaO4S (385.1072160000001)
D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors
Phosphatidyl-L-serine
[4,5-Dihydroxy-6-[4-[(methoxycarbothioylamino)methyl]phenoxy]-2-methyloxan-3-yl] acetate
C17H23NO7S (385.11951680000004)
(2R)-2-amino-3-[[(2R)-2-butanoyloxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
9-{5-S-[(3S)-3-azaniumyl-3-carboxylatopropyl]-5-thio-beta-D-ribofuranosyl}-9H-purin-6-ol
3-[(2Z,4Z)-5-carbamoyl-3-(dimethylamino)-4-hydroxypenta-2,4-dien-1-yl]-1,8-dihydroxy-4-methylnaphthalene-2-carboxylate
(4aR)-1,4a,8,10,11-pentahydroxy-3,12-dioxo-5,12a-dihydro-4H-tetracene-2-carboxamide
3-ethoxy-N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]benzamide
N-[3-(1,3-benzothiazol-2-yl)-7-propan-2-yl-4,5,6,8-tetrahydrothieno[2,3-c]azepin-2-yl]acetamide
4-[4-[(2-Oxo-1,3-dihydroindol-5-yl)sulfonyl]piperazin-1-yl]benzaldehyde
C19H19N3O4S (385.10962140000004)
N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-4,5,7,8-tetrahydrothieno[2,3-d]azepin-2-yl]acetamide
(7S)-7-acetamido-1,2,3-trimethoxy-6,7-dihydro-5H-dibenzo[5,3-b:1,2-e][7]annulene-9-carboxylic acid
2,5-dimethoxy-N-(4-phenoxyphenyl)benzenesulfonamide
C20H19NO5S (385.0983884000001)
Versicolorone(1-)
An organic anion that is the conjugate base of versicolorone, obtained by selective deprotonation of the 2-hydroxy group.
4-fluoro-N-[3-[2-nitro-4-(trifluoromethyl)anilino]propyl]benzamide
(2S)-versicolorone(1-)
An organic anion obtained by selective deprotonation of the 2-hydroxy group of (2S)-versicolorone.
1-[1-[2-(4-Methoxyphenyl)ethyl]-2,5-dimethyl-3-pyrrolyl]-2-[(1-methyl-5-tetrazolyl)thio]ethanone
vittatine Trifluoroacetic acid
A natural product found in Crinum asiaticum var. sinicum.
(S)-5-oxoaverantin(1-)
A phenolate anion obtained by deprotonation of the 2-hydroxy group of (S)-5-oxoaverantin. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
4,5-Dimethyl-2-[[1-oxo-2-(4-quinazolinyloxy)ethyl]amino]-3-thiophenecarboxylic acid ethyl ester
C19H19N3O4S (385.10962140000004)
N-[5-[(3,4-dimethoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-4-methoxybenzamide
C19H19N3O4S (385.10962140000004)
4-[[3-[[(4-Nitrophenyl)-oxomethyl]amino]-1-oxopropyl]amino]benzoic acid ethyl ester
8-O-demethyloxomaritidine Trifluoroacetic acid
A natural product found in Crinum asiaticum var. sinicum.
ethyl 1-[(4-oxo-4H-pyrido[1,2-a]thieno[2,3-d]pyrimidin-2-yl)carbonyl]piperidine-4-carboxylate
C19H19N3O4S (385.10962140000004)
4-(3-hydroxyphenyl)-1-(thiophen-2-ylmethyl)-4H-pyridine-3,5-dicarboxylic acid dimethyl ester
C20H19NO5S (385.0983884000001)
3-(2-furanylmethyl)-4-oxo-N,N-dipropyl-2-sulfanylidene-1H-quinazoline-7-carboxamide
2-[4-oxo-2-(1-piperidinyl)-5-thiazolyl]-N-[3-(trifluoromethyl)phenyl]acetamide
1-benzyl-2-methyl-3-{(E)-[2-(5-nitropyridin-2-yl)hydrazinylidene]methyl}-1H-indole
2-amino-7-hydroxy-4,4,6-trimethyl-2-oxo-4H-spiro[chromene-4,1-pyrrolo[3,2,1-ij]quinoline]-3-carbonitrile
2-[[3-[4-(Dimethylamino)phenyl]-4,5-dihydroisoxazol-5-yl]methyl]-1,1-dioxo-1,2-benzothiazol-3-one
C19H19N3O4S (385.10962140000004)
3,4-dimethoxy-N-[[4-(1-pyrrolidinyl)anilino]-sulfanylidenemethyl]benzamide
2-[[4-(3-Methoxyphenyl)-5-[(4-methylphenoxy)methyl]-1,2,4-triazol-3-yl]thio]acetic acid
C19H19N3O4S (385.10962140000004)
1-[1-[(2-Chloro-6-fluorophenyl)methyl]-2-oxo-3-pyridinyl]-3-(phenylmethyl)urea
N-(4-chlorophenyl)-N-ethyl-6-(propan-2-ylamino)-4-(trifluoromethyl)-3-pyridinecarboxamide
4-[oxo-(4-oxo-5H-thieno[3,2-c]quinolin-2-yl)methyl]-1-piperazinecarboxylic acid ethyl ester
C19H19N3O4S (385.10962140000004)
1-(4-oxo-2-thieno[3,2-d][1,3]thiazinyl)-N-(phenylmethyl)-3-piperidinecarboxamide
C19H19N3O2S2 (385.09186339999997)
4-methyl-2-[3-methyl-4-(3-methylphenyl)azo-5-oxo-4H-pyrazol-1-yl]-5-thiazolecarboxylic acid ethyl ester
[4-[(Z)-2-cyano-2-(6-methyl-1H-benzimidazol-2-yl)ethenyl]phenyl] thiophene-2-carboxylate
N-(1,3-benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)-4-quinazolinamine
N-[(2-chlorophenyl)-oxomethyl]-1-ethyl-4-hydroxy-2-oxo-3-quinolinecarbohydrazide
C19H16ClN3O4 (385.08292860000006)
epivittatine Trifluoroacetic acid
A natural product found in Crinum asiaticum var. sinicum.
(3R,6R,14aR,14bR)-3-[(1R)-1-chloroethyl]-3,6-dihydroxy-6-methyl-5-methylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione
C18H24ClNO6 (385.12920740000004)
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
N-[(2R,3S,6R)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide
N-[(2R,3R,6R)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
N-[(2S,3R,6S)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide
N-[(2S,3S,6S)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide
N-[(2S,3S,6R)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide
N-[(2R,3R,6S)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide
2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-D-glucitol
C14H27NO11 (385.15840319999995)
jacoline N-oxide
A pyrrolizine alkaloid that is jacoline in which the tertiary amino function has been oxidised to the corresponding N-oxide.
3-(beta-D-Glucopyranosyloxy)-2-phenyl-1-benzopyrylium
2-aminoethyl 4-O-beta-D-glucopyranosyl-alpha-D-glucopyranoside
C14H27NO11 (385.15840319999995)
2-acetamido-2-deoxy-3-O-D-galactopyranosyl-D-galactitol
C14H27NO11 (385.15840319999995)
N-[(2S,3R,4R,5R)-1,3,5,6-Tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide
C14H27NO11 (385.15840319999995)
N-[(2S,3R,4S,5R)-1,3,4,5-Tetrahydroxy-6-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide
C14H27NO11 (385.15840319999995)
1-[2-(Diethylamino)ethyl]-5-pyridin-2-yl-4-(thiophene-2-carbonyl)pyrrolidine-2,3-dione
2-aminoethyl 4-O-alpha-D-glucopyranosyl-alpha-D-galactopyranoside
C14H27NO11 (385.15840319999995)
[5-[2-amino-5-(methylaminomethyl)-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-hydroxy-2,5-dihydrofuran-2-yl]methyl phosphate
N-[(3S)-1-quinolin-4-ylpyrrolidin-3-yl]-3-(trifluoromethyl)benzamide
2-Amino-3-[(2-butanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[hydroxy-(2-hydroxy-3-octanoyloxypropoxy)phosphoryl]oxypropanoic acid
C14H28NO9P (385.15016080000004)
3-[(3-Acetyloxy-2-pentanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid
TEPOXALIN
C20H20ClN3O3 (385.11931200000004)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Tepoxalin is a dual inhibitor of COX and 5-lipoxygenase (5-LO) with potent anti-inflammatory activity and a favorable gastrointestinal profile[1].
3,4-DI-1H-Indol-3-YL-1H-pyrrole-2,5-dicarboxylic acid
C22H15N3O4 (385.10625100000004)
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronide
(1Z)-1-[(2-hydroxy-3,4-dimethoxyphenyl)methylidene]-6,7-dimethoxy-3,4-dihydroisoquinoline-2-carbaldehyde
S-inosyl-L-homocysteine zwitterion
Zwitterionic form of S-inosyl-L-homocysteine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.
nocardicin G zwitterion
An amino acid zwitterion resulting from a transfer of a proton from the carboxy group to the amino group of nocardicin G; major species at pH 7.3.
2-Hydroxymethyl-5-[6-(1-methyl-2-phenyl-ethylamino)-purin-9-yl]-tetrahydro-furan-3,4-diol
C19H23N5O4 (385.17499580000003)
D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents
dehydrojaconine
C18H24ClNO6 (385.12920740000004)
A pyrrolizine alkaloid that is jacoline in which the secondary hydroxy group has been replaced by a chlorine and the 5-methyl group has been replaced by methylene.
KJ Pyr 9
C22H15N3O4 (385.10625100000004)
KJ Pyr 9 is an inhibitor of MYC with a Kd of 6.5 nM in in vitro assay.
SKI-349
C19H19N3O4S (385.10962140000004)
SKI-349 is a dual-targeted inhibitor of sphingosine kinase 1/2 (SPHK1/2) and microtubule assembly (MDA). SKI-349 has anticancer activity. SKI-349 can inhibit the vitality, invasion, and AKT/mTOR signaling pathway of liver cells[1][2].
(1r,11s,13s)-11,16,17-trimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaene
(16s,20s,23s)-17-hydroxy-13-methoxy-20,23-dimethyl-1,11,18-triazahexacyclo[10.8.2.1¹⁶,²⁰.0²,⁷.0⁸,²².0¹⁵,²¹]tricosa-2,4,6,8(22),9,11,13,15(21),17-nonaen-19-one
2,3-dimethoxy-6-({6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}methyl)benzoic acid
5-[(r)-hydroxy[(5s)-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]methyl]-2h-1,3-benzodioxole-4-carboxylic acid
C20H19NO7 (385.11614640000005)
(12bs)-2-hydroxy-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-6-azatetraphen-5-one
(1r,11r,13s)-16,17-dimethoxy-22-methyl-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaen-11-ol
3,4-bis(4-hydroxyphenyl)-1-(2-phenylethyl)pyrrole-2,5-dione
1,4-dihydroxy-3-[(6r)-6-(hydroxymethyl)-4-methylocta-2,4-dienoyl]-5-(4-hydroxyphenyl)pyridin-2-one
(2s)-2-amino-3-{[2-(butanoyloxy)-3-(propanoyloxy)propoxy(hydroxy)phosphoryl]oxy}propanoic acid
(16r,20r,21s)-17-hydroxy-13-methoxy-20,21-dimethyl-1,11,18-triazahexacyclo[10.9.2.0²,⁷.0⁸,²³.0¹⁵,²².0¹⁶,²⁰]tricosa-2,4,6,8(23),9,11,13,15(22),17-nonaen-19-one
(1r,11s)-11,16,17-trimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaene
12,16-dimethoxy-21-methyl-4,6-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0³,⁷.0¹³,¹⁸]henicosa-2,7,9,13(18),14,16-hexaene-1,15-diol
[(3r)-2,3-dihydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}indol-3-yl]acetic acid
n-{4-hydroxy-3,5,14-trimethoxy-13-oxotetracyclo[9.5.0.0²,⁷.0¹²,¹⁶]hexadeca-1(11),2,4,6,14-pentaen-10-yl}ethanimidic acid
methyl 5-hydroxy-4,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaene-10-carboxylate
aristolochicacid iva methyl ester
{"Ingredient_id": "HBIN016810","Ingredient_name": "aristolochicacid iva methyl ester","Alias": "NA","Ingredient_formula": "C19H15NO8","Ingredient_Smile": "COC1=CC2=C3C(=C(C=C2C(=C1)OC)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1720","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
β-hydrastine
{"Ingredient_id": "HBIN018149","Ingredient_name": "\u03b2-hydrastine","Alias": "NA","Ingredient_formula": "C21H23NO6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9701","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(16r,20s,23r)-17-hydroxy-13-methoxy-20,23-dimethyl-1,11,18-triazahexacyclo[10.8.2.1¹⁶,²⁰.0²,⁷.0⁸,²².0¹⁵,²¹]tricosa-2,4,6,8(22),9,11,13,15(21),17-nonaen-19-one
3-({3-[(4-hydroxyphenyl)methanethioamido]-1-sulfanylpropylidene}amino)-n-(3-hydroxypropyl)propanimidothioic acid
n-{3,4,5,14-tetramethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}carboximidic acid
1,12,15-trihydroxy-16-methoxy-21-methyl-6,8-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0⁵,⁹.0¹³,¹⁸]henicosa-2(10),3,5(9),13(18),14,16-hexaen-11-one
C20H19NO7 (385.11614640000005)
(12s)-7,16,17-trimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14(19),15,17-hexaen-15-ol
n-[(10s)-5-hydroxy-3,4,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl]ethanimidic acid
n-[(10r)-5-hydroxy-3,4,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl]ethanimidic acid
6',7'-dimethoxy-2'-methyl-3',4',6,8-tetrahydro-2h-spiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinoline]-6,8-diol
3,4-dimethoxy-2-({5-oxo-2h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-6-yl}methyl)benzoic acid
C20H19NO7 (385.11614640000005)
(6s,7r,8r)-6',7'-dimethoxy-2'-methyl-3',4',6,8-tetrahydro-2h-spiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinoline]-6,8-diol
n-{4-[(4s)-2-(2,3-dihydroxyphenyl)-4,5-dihydro-3h-imidazol-4-yl]butyl}-2,3-dihydroxybenzenecarboximidic acid
C20H23N3O5 (385.16376280000003)
2,3-dimethoxy-6-{[(5s)-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]methyl}benzoic acid
n-{14-hydroxy-3,4,5-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}ethanimidic acid
n-[(10s,12r,16s)-4-hydroxy-3,5,14-trimethoxy-13-oxotetracyclo[9.5.0.0²,⁷.0¹²,¹⁶]hexadeca-1(11),2,4,6,14-pentaen-10-yl]ethanimidic acid
(1s,12s)-1,12,15-trihydroxy-16-methoxy-21-methyl-6,8-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0⁵,⁹.0¹³,¹⁸]henicosa-2(10),3,5(9),13(18),14,16-hexaen-11-one
C20H19NO7 (385.11614640000005)
n-[(10s)-3,4,5,14-tetramethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl]carboximidic acid
n-[(10s)-14-hydroxy-3,4,5-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl]ethanimidic acid
(19s,21s)-9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7(12),9-diene-8,11-dione
C20H23N3O5 (385.16376280000003)
(2r,3s,4r,5r,6r)-4,5-dihydroxy-6-[4-({[methoxy(sulfanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetate
C17H23NO7S (385.11951680000004)
4,5-dihydroxy-6-[4-({[methoxy(sulfanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetate
C17H23NO7S (385.11951680000004)
2-amino-3-{[2-(butanoyloxy)-3-(propanoyloxy)propoxy(hydroxy)phosphoryl]oxy}propanoic acid
16,17-dimethoxy-22-methyl-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaen-11-ol
(16s,20s,23r)-17-hydroxy-13-methoxy-20,23-dimethyl-1,11,18-triazahexacyclo[10.8.2.1¹⁶,²⁰.0²,⁷.0⁸,²².0¹⁵,²¹]tricosa-2,4,6,8(22),9,11,13,15(21),17-nonaen-19-one
methyl (9s)-5-hydroxy-4,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaene-10-carboxylate
2-hydroxy-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-6-azatetraphen-5-one
(3r)-4-(1,4-dihydroxy-5-methoxy-9,10-dioxoanthracen-2-yl)-3-hydroxy-3-methylbutanimidic acid
C20H19NO7 (385.11614640000005)
1,6-dihydroxy-4-(2-hydroxy-3-methylbut-3-en-1-yl)-3,5-dimethoxy-10-methylacridin-9-one
2-(2-{[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-hydroxyethyl)-6-methoxyoxane-3,4,5-triol
C14H27NO11 (385.15840319999995)
11,16,17-trimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaene
methyl 3-hydroxy-4,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaene-10-carboxylate
methyl (2r)-2,3-dihydroxy-2-[(2r)-5-hydroxy-11-methyl-6-oxo-1h,2h-furo[2,3-c]acridin-2-yl]propanoate
C20H19NO7 (385.11614640000005)
n-[(10r)-4-hydroxy-3,5,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl]ethanimidic acid
methyl 2,3-dihydroxy-2-{5-hydroxy-11-methyl-6-oxo-1h,2h-furo[2,3-c]acridin-2-yl}propanoate
C20H19NO7 (385.11614640000005)
n-[(10r)-3,4,5,14-tetramethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl]carboximidic acid
5-[hydroxy({6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl})methyl]-2h-1,3-benzodioxole-4-carboxylic acid
C20H19NO7 (385.11614640000005)
(2,3-dihydroxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}indol-3-yl)acetic acid
1,6-dihydroxy-4-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-3,5-dimethoxy-10-methylacridin-9-one
7,16,17-trimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14(19),15,17-hexaen-15-ol
(1r,3r,6r,13r,18r,19s,21s,23r)-9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7(12),9-diene-8,11-dione
C20H23N3O5 (385.16376280000003)
9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7(12),9-diene-8,11-dione
C20H23N3O5 (385.16376280000003)
n-{4-hydroxy-3,5,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}ethanimidic acid
1,4-dihydroxy-3-[6-(hydroxymethyl)-4-methylocta-2,4-dienoyl]-5-(4-hydroxyphenyl)pyridin-2-one
(1s,11s,13s)-11,16,17-trimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaene
n-{4-[2-(2,3-dihydroxyphenyl)-4,5-dihydro-3h-imidazol-4-yl]butyl}-2,3-dihydroxybenzenecarboximidic acid
C20H23N3O5 (385.16376280000003)
1,4-dihydroxy-3-[(2e,4e,6r)-6-(hydroxymethyl)-4-methylocta-2,4-dienoyl]-5-(4-hydroxyphenyl)pyridin-2-one
(1s,14r,21r)-18,19-dimethoxy-13-methyl-5,7,22-trioxa-13-azapentacyclo[12.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]docosa-2,4(8),9,15,17,19-hexaen-21-ol
n-{5-hydroxy-3,4,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl}ethanimidic acid
(2s,3r,4s,5r,6s)-4,5-dihydroxy-6-[4-({[methoxy(sulfanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetate
C17H23NO7S (385.11951680000004)
17-hydroxy-13-methoxy-20,23-dimethyl-1,11,18-triazahexacyclo[10.8.2.1¹⁶,²⁰.0²,⁷.0⁸,²².0¹⁵,²¹]tricosa-2,4,6,8(22),9,11,13,15(21),17-nonaen-19-one
1-[(2-hydroxy-3,4-dimethoxyphenyl)methylidene]-6,7-dimethoxy-3,4-dihydroisoquinoline-2-carbaldehyde
(16r,20r,23r)-17-hydroxy-13-methoxy-20,23-dimethyl-1,11,18-triazahexacyclo[10.8.2.1¹⁶,²⁰.0²,⁷.0⁸,²².0¹⁵,²¹]tricosa-2,4,6,8(22),9,11,13,15(21),17-nonaen-19-one
methyl (9r)-3-hydroxy-4,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaene-10-carboxylate
(1r,12r)-12,16-dimethoxy-21-methyl-4,6-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0³,⁷.0¹³,¹⁸]henicosa-2,7,9,13(18),14,16-hexaene-1,15-diol
(16r,20r,23s)-17-hydroxy-13-methoxy-20,23-dimethyl-1,11,18-triazahexacyclo[10.8.2.1¹⁶,²⁰.0²,⁷.0⁸,²².0¹⁵,²¹]tricosa-2,4,6,8(22),9,11,13,15(21),17-nonaen-19-one
methyl 8,10-dimethoxy-6-nitro-2h-phenanthro[3,4-d][1,3]dioxole-5-carboxylate
(1r,4r,7r,17r)-4-(1-chloroethyl)-4,7-dihydroxy-7-methyl-6-methylidene-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione
C18H24ClNO6 (385.12920740000004)
(1s,11r,13s)-16,17-dimethoxy-22-methyl-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaen-11-ol
6,11-dihydroxy-2,2-dimethyl-12-phenyl-5h-1-oxa-5-azatetraphen-10-one
(2e,4e,6r,7r)-1-[2,4-dihydroxy-5-(4-hydroxyphenyl)pyridin-3-yl]-7-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dien-1-one
(2r,3s,4s,5s,6s)-2-[(1s)-2-{[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-hydroxyethyl]-6-methoxyoxane-3,4,5-triol
C14H27NO11 (385.15840319999995)